1. Home
  2. EVTL vs ABEO Comparison

EVTL vs ABEO Comparison

Compare EVTL & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertical Aerospace Ltd.

EVTL

Vertical Aerospace Ltd.

BUY

Current Price

$0.39

Market Cap

235.6M

Sector

Industrials

ML Signal

BUY

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$4.41

Market Cap

282.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTL
ABEO
Founded
2016
1974
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.6M
282.5M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
EVTL
ABEO
Price
$0.39
$4.41
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$6.92
★ $18.88
AVG Volume (30 Days)
★ 4.6M
1.1M
Earning Date
08-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 165.16
EPS
★ N/A
N/A
Revenue
N/A
★ $2,998,000.00
Revenue This Year
N/A
$804.33
Revenue Next Year
N/A
$119.68
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 258.18
52 Week Low
$0.34
$4.00
52 Week High
$7.35
$7.65

Technical Indicators

Market Signals
Indicator
EVTL
ABEO
Relative Strength Index (RSI) 31.92 33.10
Support Level $0.34 $4.26
Resistance Level $0.80 $5.83
Average True Range (ATR) 0.05 0.22
MACD -0.00 -0.00
Stochastic Oscillator 20.10 12.50

Price Performance

Historical Comparison
EVTL
ABEO

About EVTL Vertical Aerospace Ltd.

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero-emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Share on Social Networks: